LGM Pharma Thyroid Powder Recall: Inconsistent Active Ingredients
LGM Pharma recalls Thyroid Powder (25kg drums) due to inconsistent levothyroxine and liothyronine levels. This may affect medication effectiveness. Contact for details.
Lower-risk recall
CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Contact the company
What happened, in plain English
LGM Pharma is recalling thyroid powder for inconsistent active ingredient levels. This could lead to incorrect dosing and health risks if used without proper medical supervision. Read more at govinfonow.com/recall/39679-lgm-pharma-thyroid-powder-recall-inconsistent-active-ingredients.
Source Summary by GovInfoNow · govinfonow.com/recall/39679-lgm-pharma-thyroid-powder-recall-inconsistent-active-ingredients · Updated October 6, 2026 · FDA enforcement record: FDA #D-0296-2019
Cite this page
“LGM Pharma Thyroid Powder Recall: Inconsistent Active Ingredients.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39679-lgm-pharma-thyroid-powder-recall-inconsistent-active-ingredients. Based on FDA recall #D-0296-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0296-2019%22&limit=1).
Why it’s dangerous
The thyroid powder has inconsistent levels of levothyroxine and liothyronine, which are critical for thyroid hormone replacement. This inconsistency could lead to incorrect dosing and health complications if not properly managed by a healthcare provider.
Who’s affected
Patients prescribed thyroid medication who use this specific product. Those with thyroid conditions require precise dosing.
How to tell if you have this one
Check for the product name 'Thyroid Powder, USP, 25kg/drum', Rx Only, with NDC 070870-1701-1. Look for lots 161101 (exp 11/2/2016), 161201 (exp Nov 2018), 170301 (exp Feb 2019), 170501 (exp Apr 2019), or 170701 (exp Jun 2019).
- Brand
LGM Pharma- Category
Drug
What to do — step by step
Check Product Details
Verify the product name, NDC, and lot numbers listed in the recall notice.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 5 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0296-2019 (August 24, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0296-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.